Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. (CMOPF) Stock Competitors & Peer Comparison
See (CMOPF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMOPF | $159.00 | -0.63% | 2.5B | 37.36 | $4.23 | +1.52% |
| BMYMP | $1,002.93 | +0.29% | 2T | 4457.47 | $0.23 | +4.11% |
| RHHBF | $483.97 | -0.62% | 385.2B | 23.21 | $20.85 | +2.27% |
| RHHBY | $59.18 | +0.00% | 382B | 22.81 | $2.60 | +1.45% |
| RHHVF | $477.44 | +0.00% | 366.2B | 22.06 | $20.85 | +2.39% |
| AZNCF | $208.62 | -0.02% | 323.4B | 34.60 | $6.03 | +1.51% |
| NVSEF | $166.34 | +3.00% | 317.4B | 23.23 | $7.16 | +2.39% |
| GLAXF | $31.48 | +0.02% | 125.9B | 16.51 | $1.89 | +2.83% |
| SNYNF | $93.97 | +0.00% | 115B | 19.84 | $4.79 | +4.64% |
| CHGCY | $30.75 | +0.00% | 105.8B | 37.39 | $0.86 | +2.56% |
Stock Comparison
CMOPF vs BMYMP Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, BMYMP has a market cap of 2T. Regarding current trading prices, CMOPF is priced at $159.00, while BMYMP trades at $1,002.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas BMYMP's P/E ratio is 4457.47. In terms of profitability, CMOPF's ROE is +0.12%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CMOPF is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check BMYMP's competition here
CMOPF vs RHHBF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, RHHBF has a market cap of 385.2B. Regarding current trading prices, CMOPF is priced at $159.00, while RHHBF trades at $483.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas RHHBF's P/E ratio is 23.21. In terms of profitability, CMOPF's ROE is +0.12%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CMOPF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RHHBF's competition here
CMOPF vs RHHBY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, RHHBY has a market cap of 382B. Regarding current trading prices, CMOPF is priced at $159.00, while RHHBY trades at $59.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas RHHBY's P/E ratio is 22.81. In terms of profitability, CMOPF's ROE is +0.12%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CMOPF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RHHBY's competition here
CMOPF vs RHHVF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, RHHVF has a market cap of 366.2B. Regarding current trading prices, CMOPF is priced at $159.00, while RHHVF trades at $477.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas RHHVF's P/E ratio is 22.06. In terms of profitability, CMOPF's ROE is +0.12%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CMOPF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check RHHVF's competition here
CMOPF vs AZNCF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, AZNCF has a market cap of 323.4B. Regarding current trading prices, CMOPF is priced at $159.00, while AZNCF trades at $208.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas AZNCF's P/E ratio is 34.60. In terms of profitability, CMOPF's ROE is +0.12%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CMOPF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check AZNCF's competition here
CMOPF vs NVSEF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, NVSEF has a market cap of 317.4B. Regarding current trading prices, CMOPF is priced at $159.00, while NVSEF trades at $166.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas NVSEF's P/E ratio is 23.23. In terms of profitability, CMOPF's ROE is +0.12%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, CMOPF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check NVSEF's competition here
CMOPF vs GLAXF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, GLAXF has a market cap of 125.9B. Regarding current trading prices, CMOPF is priced at $159.00, while GLAXF trades at $31.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas GLAXF's P/E ratio is 16.51. In terms of profitability, CMOPF's ROE is +0.12%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, CMOPF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GLAXF's competition here
CMOPF vs SNYNF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, SNYNF has a market cap of 115B. Regarding current trading prices, CMOPF is priced at $159.00, while SNYNF trades at $93.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas SNYNF's P/E ratio is 19.84. In terms of profitability, CMOPF's ROE is +0.12%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNYNF's competition here
CMOPF vs CHGCY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, CHGCY has a market cap of 105.8B. Regarding current trading prices, CMOPF is priced at $159.00, while CHGCY trades at $30.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas CHGCY's P/E ratio is 37.39. In terms of profitability, CMOPF's ROE is +0.12%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, CMOPF is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CHGCY's competition here
CMOPF vs CHGCF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, CHGCF has a market cap of 102B. Regarding current trading prices, CMOPF is priced at $159.00, while CHGCF trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas CHGCF's P/E ratio is 36.05. In terms of profitability, CMOPF's ROE is +0.12%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, CMOPF is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CHGCF's competition here
CMOPF vs BAYRY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, BAYRY has a market cap of 50.2B. Regarding current trading prices, CMOPF is priced at $159.00, while BAYRY trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas BAYRY's P/E ratio is -213.00. In terms of profitability, CMOPF's ROE is +0.12%, compared to BAYRY's ROE of -0.01%. Regarding short-term risk, CMOPF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check BAYRY's competition here
CMOPF vs OTSKY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, OTSKY has a market cap of 37.4B. Regarding current trading prices, CMOPF is priced at $159.00, while OTSKY trades at $33.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas OTSKY's P/E ratio is 15.30. In terms of profitability, CMOPF's ROE is +0.12%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CMOPF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OTSKY's competition here
CMOPF vs OTSKF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, OTSKF has a market cap of 37.1B. Regarding current trading prices, CMOPF is priced at $159.00, while OTSKF trades at $70.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas OTSKF's P/E ratio is 14.50. In terms of profitability, CMOPF's ROE is +0.12%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CMOPF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OTSKF's competition here
CMOPF vs DSNKY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, DSNKY has a market cap of 35.3B. Regarding current trading prices, CMOPF is priced at $159.00, while DSNKY trades at $18.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas DSNKY's P/E ratio is 19.27. In terms of profitability, CMOPF's ROE is +0.12%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, CMOPF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DSNKY's competition here
CMOPF vs DSKYF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, DSKYF has a market cap of 34.9B. Regarding current trading prices, CMOPF is priced at $159.00, while DSKYF trades at $18.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas DSKYF's P/E ratio is 19.21. In terms of profitability, CMOPF's ROE is +0.12%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, CMOPF is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DSKYF's competition here
CMOPF vs ALPMF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, ALPMF has a market cap of 29.4B. Regarding current trading prices, CMOPF is priced at $159.00, while ALPMF trades at $15.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas ALPMF's P/E ratio is 37.28. In terms of profitability, CMOPF's ROE is +0.12%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, CMOPF is less volatile compared to ALPMF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check ALPMF's competition here
CMOPF vs ALPMY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, ALPMY has a market cap of 28.5B. Regarding current trading prices, CMOPF is priced at $159.00, while ALPMY trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas ALPMY's P/E ratio is 34.63. In terms of profitability, CMOPF's ROE is +0.12%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, CMOPF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ALPMY's competition here
CMOPF vs ORINY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, ORINY has a market cap of 22.8B. Regarding current trading prices, CMOPF is priced at $159.00, while ORINY trades at $40.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas ORINY's P/E ratio is 19.23. In terms of profitability, CMOPF's ROE is +0.12%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, CMOPF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ORINY's competition here
CMOPF vs GIKLY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, GIKLY has a market cap of 17B. Regarding current trading prices, CMOPF is priced at $159.00, while GIKLY trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas GIKLY's P/E ratio is 20.16. In terms of profitability, CMOPF's ROE is +0.12%, compared to GIKLY's ROE of +0.07%. Regarding short-term risk, CMOPF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIKLY's competition here
CMOPF vs CHJTF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, CHJTF has a market cap of 15.9B. Regarding current trading prices, CMOPF is priced at $159.00, while CHJTF trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas CHJTF's P/E ratio is 27.80. In terms of profitability, CMOPF's ROE is +0.12%, compared to CHJTF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CHJTF's competition here
CMOPF vs CSPCY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, CSPCY has a market cap of 14.9B. Regarding current trading prices, CMOPF is priced at $159.00, while CSPCY trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas CSPCY's P/E ratio is 27.11. In terms of profitability, CMOPF's ROE is +0.12%, compared to CSPCY's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CSPCY's competition here
CMOPF vs ORINF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, ORINF has a market cap of 11.1B. Regarding current trading prices, CMOPF is priced at $159.00, while ORINF trades at $78.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas ORINF's P/E ratio is 25.30. In terms of profitability, CMOPF's ROE is +0.12%, compared to ORINF's ROE of +0.47%. Regarding short-term risk, CMOPF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ORINF's competition here
CMOPF vs RCDTF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, RCDTF has a market cap of 10B. Regarding current trading prices, CMOPF is priced at $159.00, while RCDTF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas RCDTF's P/E ratio is 21.40. In terms of profitability, CMOPF's ROE is +0.12%, compared to RCDTF's ROE of +0.21%. Regarding short-term risk, CMOPF is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check RCDTF's competition here
CMOPF vs GIFOF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CMOPF is priced at $159.00, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas GIFOF's P/E ratio is 13.83. In terms of profitability, CMOPF's ROE is +0.12%, compared to GIFOF's ROE of +0.07%. Regarding short-term risk, CMOPF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIFOF's competition here
CMOPF vs KYKOF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, KYKOF has a market cap of 8.2B. Regarding current trading prices, CMOPF is priced at $159.00, while KYKOF trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas KYKOF's P/E ratio is 18.70. In terms of profitability, CMOPF's ROE is +0.12%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check KYKOF's competition here
CMOPF vs GIFLF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, GIFLF has a market cap of 7.9B. Regarding current trading prices, CMOPF is priced at $159.00, while GIFLF trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas GIFLF's P/E ratio is 18.22. In terms of profitability, CMOPF's ROE is +0.12%, compared to GIFLF's ROE of +0.07%. Regarding short-term risk, CMOPF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIFLF's competition here
CMOPF vs OPHLY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, OPHLY has a market cap of 7.8B. Regarding current trading prices, CMOPF is priced at $159.00, while OPHLY trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas OPHLY's P/E ratio is 23.17. In terms of profitability, CMOPF's ROE is +0.12%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OPHLY's competition here
CMOPF vs OPHLF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, OPHLF has a market cap of 7.6B. Regarding current trading prices, CMOPF is priced at $159.00, while OPHLF trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas OPHLF's P/E ratio is 22.89. In terms of profitability, CMOPF's ROE is +0.12%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OPHLF's competition here
CMOPF vs DPHAY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CMOPF is priced at $159.00, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CMOPF's ROE is +0.12%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CMOPF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DPHAY's competition here
CMOPF vs SNPHY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, CMOPF is priced at $159.00, while SNPHY trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas SNPHY's P/E ratio is 18.82. In terms of profitability, CMOPF's ROE is +0.12%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, CMOPF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNPHY's competition here
CMOPF vs PTKFF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, PTKFF has a market cap of 3.2B. Regarding current trading prices, CMOPF is priced at $159.00, while PTKFF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CMOPF's ROE is +0.12%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check PTKFF's competition here
CMOPF vs HAWPF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, HAWPF has a market cap of 3.1B. Regarding current trading prices, CMOPF is priced at $159.00, while HAWPF trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas HAWPF's P/E ratio is 15.74. In terms of profitability, CMOPF's ROE is +0.12%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check HAWPF's competition here
CMOPF vs SNPHF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, SNPHF has a market cap of 3.1B. Regarding current trading prices, CMOPF is priced at $159.00, while SNPHF trades at $9.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas SNPHF's P/E ratio is 16.12. In terms of profitability, CMOPF's ROE is +0.12%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, CMOPF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNPHF's competition here
CMOPF vs VRBCF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, CMOPF is priced at $159.00, while VRBCF trades at $346.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas VRBCF's P/E ratio is 17.04. In terms of profitability, CMOPF's ROE is +0.12%, compared to VRBCF's ROE of +0.13%. Regarding short-term risk, CMOPF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check VRBCF's competition here
CMOPF vs HAWPY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, HAWPY has a market cap of 2.7B. Regarding current trading prices, CMOPF is priced at $159.00, while HAWPY trades at $49.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas HAWPY's P/E ratio is 13.77. In terms of profitability, CMOPF's ROE is +0.12%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check HAWPY's competition here
CMOPF vs LYPHF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, LYPHF has a market cap of 1.5B. Regarding current trading prices, CMOPF is priced at $159.00, while LYPHF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas LYPHF's P/E ratio is 18.88. In terms of profitability, CMOPF's ROE is +0.12%, compared to LYPHF's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check LYPHF's competition here
CMOPF vs TGRNF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, CMOPF is priced at $159.00, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, CMOPF's ROE is +0.12%, compared to TGRNF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check TGRNF's competition here
CMOPF vs JCRRF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, CMOPF is priced at $159.00, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, CMOPF's ROE is +0.12%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, CMOPF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check JCRRF's competition here
CMOPF vs MAYNF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, MAYNF has a market cap of 150.7M. Regarding current trading prices, CMOPF is priced at $159.00, while MAYNF trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas MAYNF's P/E ratio is -2.35. In terms of profitability, CMOPF's ROE is +0.12%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CMOPF is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check MAYNF's competition here
CMOPF vs PTKFY Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, PTKFY has a market cap of 15.1M. Regarding current trading prices, CMOPF is priced at $159.00, while PTKFY trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas PTKFY's P/E ratio is 14.61. In terms of profitability, CMOPF's ROE is +0.12%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check PTKFY's competition here
CMOPF vs PSYGF Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, CMOPF is priced at $159.00, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, CMOPF's ROE is +0.12%, compared to PSYGF's ROE of +3.04%. Regarding short-term risk, CMOPF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check PSYGF's competition here
CMOPF vs CRXTQ Comparison February 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 2.5B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CMOPF is priced at $159.00, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 37.36, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CMOPF's ROE is +0.12%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CMOPF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CRXTQ's competition here